[144] Parker-Hannifin Corporation SEC Filing
Parker-Hannifin filed a Form 144 reporting a proposed sale of 575 shares of common stock through UBS Financial Services, with an approximate aggregate market value of $421,511. The shares were acquired on 04/24/2025 as a restricted stock unit (RSU) vest and the proposed sale date listed is 08/08/2025. The filing shows 127,778,004 shares outstanding, so the block offered represents a very small portion of the company’s total equity. The filer also indicates no securities sold during the past three months and includes the customary Form 144 representation about lack of undisclosed material information.
Parker-Hannifin ha presentato un Form 144 segnalando la proposta di vendita di 575 azioni ordinarie tramite UBS Financial Services, con un valore di mercato aggregato approssimativo di $421,511. Le azioni sono state acquisite il 04/24/2025 come vesting di restricted stock unit (RSU) e la data proposta per la vendita è indicata come 08/08/2025. La dichiarazione riporta 127,778,004 azioni in circolazione, dunque il blocco offerto rappresenta una porzione molto ridotta del capitale complessivo della società. Il dichiarante indica inoltre nessuna vendita di titoli negli ultimi tre mesi e include la consueta dichiarazione del Form 144 riguardo all’assenza di informazioni materiali non divulgate.
Parker-Hannifin presentó un Form 144 informando una propuesta de venta de 575 acciones ordinarias a través de UBS Financial Services, con un valor de mercado agregado aproximado de $421,511. Las acciones se adquirieron el 04/24/2025 como vesting de unidades de acciones restringidas (RSU) y la fecha propuesta de venta figura como 08/08/2025. La presentación muestra 127,778,004 acciones en circulación, por lo que el lote ofrecido representa una porción muy pequeña del capital total de la compañía. El declarante también indica ninguna venta de valores en los últimos tres meses e incluye la representación habitual del Form 144 sobre la ausencia de información material no divulgada.
Parker-Hannifin은 Form 144을 제출하여 UBS Financial Services를 통해 575주의 보통주 매도를 제안했다고 보고했으며, 대략적인 총 시가 $421,511으로 기재했습니다. 해당 주식은 04/24/2025에 제한주식단위(RSU)의 베스팅으로 취득되었고 제안된 매도 예정일은 08/08/2025로 기재되어 있습니다. 제출서류에는 127,778,004주의 발행 주식수가 기재되어 있어, 제시된 블록은 회사 전체 지분에서 매우 작은 비중을 차지합니다. 제출인은 또한 지난 3개월 동안 매도한 증권 없음을 표기했으며, 공개되지 않은 중요 정보가 없다는 Form 144의 통상적 진술을 포함했습니다.
Parker-Hannifin a déposé un Form 144 signalant une proposition de vente de 575 actions ordinaires via UBS Financial Services, pour une valeur de marché agrégée approximative de $421,511. Les actions ont été acquises le 04/24/2025 lors du vesting d’unités d’actions restreintes (RSU) et la date de vente proposée est indiquée au 08/08/2025. Le dépôt fait état de 127,778,004 actions en circulation ; le lot proposé représente donc une part très réduite du capital total de la société. Le déclarant indique également aucune vente de titres au cours des trois derniers mois et inclut la représentation habituelle du Form 144 concernant l’absence d’informations matérielles non divulguées.
Parker-Hannifin hat ein Form 144 eingereicht und einen beabsichtigten Verkauf von 575 Stammaktien über UBS Financial Services gemeldet, mit einem ungefähren Gesamtmarktwert von $421,511. Die Aktien wurden am 04/24/2025 als Vesting von Restricted Stock Units (RSU) erworben, und das angegebene geplante Verkaufsdatum ist der 08/08/2025. Die Einreichung weist 127,778,004 ausstehende Aktien aus, sodass das angebotene Paket nur einen sehr kleinen Teil des Gesamtkapitals des Unternehmens darstellt. Der Melder gibt außerdem an, dass in den letzten drei Monaten keine Wertpapiere verkauft wurden, und fügt die übliche Form-144-Erklärung zur Abwesenheit nicht veröffentlichter wesentlicher Informationen bei.
- Securities were acquired via RSU vesting, indicating the sale is monetization of compensation rather than a market-timed disposition.
- Filer reports no securities sold during the past three months, suggesting this is an isolated planned sale.
- None.
Insights
TL;DR: Insider sale size is immaterial relative to shares outstanding; proceeds stem from RSU vesting.
The filing discloses a planned sale of 575 shares with an aggregate market value of $421,511. The shares were acquired via an RSU vest on 04/24/2025 and are to be sold on 08/08/2025. Compared with the reported 127,778,004 shares outstanding, the transaction is de minimis in scale and unlikely to move market valuations or signal a change in company fundamentals. Disclosure is routine under Rule 144.
TL;DR: Transaction appears to be routine compensation monetization and the filing follows required disclosure and attestation language.
The notice shows the securities were received through an RSU vest and will be sold through a broker. The filer attests they are not aware of undisclosed material adverse information, a standard representation on Form 144. There are no reported sales in the prior three months, and the transaction size is modest versus total shares outstanding, so governance or signaling concerns are limited based on this filing alone.
Parker-Hannifin ha presentato un Form 144 segnalando la proposta di vendita di 575 azioni ordinarie tramite UBS Financial Services, con un valore di mercato aggregato approssimativo di $421,511. Le azioni sono state acquisite il 04/24/2025 come vesting di restricted stock unit (RSU) e la data proposta per la vendita è indicata come 08/08/2025. La dichiarazione riporta 127,778,004 azioni in circolazione, dunque il blocco offerto rappresenta una porzione molto ridotta del capitale complessivo della società. Il dichiarante indica inoltre nessuna vendita di titoli negli ultimi tre mesi e include la consueta dichiarazione del Form 144 riguardo all’assenza di informazioni materiali non divulgate.
Parker-Hannifin presentó un Form 144 informando una propuesta de venta de 575 acciones ordinarias a través de UBS Financial Services, con un valor de mercado agregado aproximado de $421,511. Las acciones se adquirieron el 04/24/2025 como vesting de unidades de acciones restringidas (RSU) y la fecha propuesta de venta figura como 08/08/2025. La presentación muestra 127,778,004 acciones en circulación, por lo que el lote ofrecido representa una porción muy pequeña del capital total de la compañía. El declarante también indica ninguna venta de valores en los últimos tres meses e incluye la representación habitual del Form 144 sobre la ausencia de información material no divulgada.
Parker-Hannifin은 Form 144을 제출하여 UBS Financial Services를 통해 575주의 보통주 매도를 제안했다고 보고했으며, 대략적인 총 시가 $421,511으로 기재했습니다. 해당 주식은 04/24/2025에 제한주식단위(RSU)의 베스팅으로 취득되었고 제안된 매도 예정일은 08/08/2025로 기재되어 있습니다. 제출서류에는 127,778,004주의 발행 주식수가 기재되어 있어, 제시된 블록은 회사 전체 지분에서 매우 작은 비중을 차지합니다. 제출인은 또한 지난 3개월 동안 매도한 증권 없음을 표기했으며, 공개되지 않은 중요 정보가 없다는 Form 144의 통상적 진술을 포함했습니다.
Parker-Hannifin a déposé un Form 144 signalant une proposition de vente de 575 actions ordinaires via UBS Financial Services, pour une valeur de marché agrégée approximative de $421,511. Les actions ont été acquises le 04/24/2025 lors du vesting d’unités d’actions restreintes (RSU) et la date de vente proposée est indiquée au 08/08/2025. Le dépôt fait état de 127,778,004 actions en circulation ; le lot proposé représente donc une part très réduite du capital total de la société. Le déclarant indique également aucune vente de titres au cours des trois derniers mois et inclut la représentation habituelle du Form 144 concernant l’absence d’informations matérielles non divulguées.
Parker-Hannifin hat ein Form 144 eingereicht und einen beabsichtigten Verkauf von 575 Stammaktien über UBS Financial Services gemeldet, mit einem ungefähren Gesamtmarktwert von $421,511. Die Aktien wurden am 04/24/2025 als Vesting von Restricted Stock Units (RSU) erworben, und das angegebene geplante Verkaufsdatum ist der 08/08/2025. Die Einreichung weist 127,778,004 ausstehende Aktien aus, sodass das angebotene Paket nur einen sehr kleinen Teil des Gesamtkapitals des Unternehmens darstellt. Der Melder gibt außerdem an, dass in den letzten drei Monaten keine Wertpapiere verkauft wurden, und fügt die übliche Form-144-Erklärung zur Abwesenheit nicht veröffentlichter wesentlicher Informationen bei.
FAQ
What did Parker-Hannifin (PH) file in this Form 144?
When were the shares acquired and how were they obtained (PH)?
What is the proposed sale date and aggregate market value (PH)?
How many Parker-Hannifin shares are outstanding according to the filing?
Were there other insider sales in the past three months for PH?
